Table of Contents
- Overview
- Results
- Risks
- Prevention
Cerebrospinal fluid - immunofixation
What the risks are
See:
Previous Section
Next Section
CSF oligoclonal banding Prevention
Review Date: 04/30/2011
Reviewed By: Kevin Sheth, MD, Department of Neurology, University of Maryland
School of Medicine, Baltimore, MD. Review provided by VeriMed
Healthcare Network. Also reviewed by David C. Dugdale, III, MD,
Professor of Medicine, Division of General Medicine, Department of
Medicine, University of Washington School of Medicine;David Zieve,
MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
